Journal
MOLECULAR ASPECTS OF MEDICINE
Volume 34, Issue 1, Pages 30-38Publisher
ELSEVIER
DOI: 10.1016/j.mam.2012.10.003
Keywords
Obesity; Type 2 Diabetes; T cell; Regulatory T cell; Th17; Natural killer cell
Funding
- National Institutes of Health [R21DK089270]
- Boston Nutrition Obesity Research Center
Ask authors/readers for more resources
The incidences of obesity and Type 2 Diabetes (T2D) are rapidly on the rise and now considered global health epidemics. Clinical data indicate a physiologically critical connection between the metabolic and immune systems, as obese individuals are uniquely susceptible to infectious and autoimmune diseases. We discuss the relevance of mouse models of obesity and the potential development of a 'biomarker toolkit' from human blood, along with the current knowledge regarding immune cell profiles in blood and adipose tissue of obese individuals with or without concomitant diseases such as T2D and Metabolic Syndrome. Understanding how the immune system initiates, perpetuates, and/or exacerbates obesity-associated diseases could lead to novel immune-based therapies for the abrogation of disease progression especially in pre-diabetic patients. (C) 2012 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available